Latest News

Adderall shortage reported by pharmacies, patients


 

Adderall, the attention-deficit/hyperactivity disorder medication, is in short supply in some parts of the nation, pharmacy chains and Adderall users say.

Half a dozen people told Bloomberg that pharmacies told them in August and September that the drug was out of stock. The patients were told the drug might not be available for weeks, though it’s supposed to be taken daily. BuzzFeed News said 20 people across the nation said that their pharmacies didn’t have Adderall in stock.

“It’s so frustrating that getting my meds requires me to be organized, focused, and motivated – all the things I’m on these meds to help with,” Irene Kelly, who has been using Adderall for 14 years, told BuzzFeed News.

Two pharmacy chains told Bloomberg that Adderall has not always been available to sell. Walgreens spokesperson Rebekah Pajak said there were “supply chain challenges” affecting instant-release and extended-release versions of the drug. CVS pharmacies can fill Adderall prescriptions “in most cases,” CVS spokesperson Matthew Blanchette said.

Several drugmakers have had brand-name and generic versions of Adderall on back order for months, Bloomberg reported. The problem started with a labor shortage at Teva Pharmaceutical, the top seller of Adderall in the United States, that created a limited supply of brand-name and generic instant-release Adderall, according to the outlet.

That said, the Food and Drug Administration is not reporting an Adderall shortage on its drug shortages database. The federal agency says it lists a drug as being in short supply when “overall market demand is not being met by the manufacturers of the product,” Bloomberg said.

“Manufacturers continue to release product,” FDA spokesperson Cherie Duvall-Jones said, according to Bloomberg.

Demand for Adderall is growing, possibly because of rising ADHD diagnoses that occurred during telehealth medical appointments amid the COVID-19 pandemic, Bloomberg reported, noting that some of those telehealth companies have come under scrutiny by the Drug Enforcement Administration and other government agencies.

NBC News, citing IQVIA, an analytics provider for the life sciences industry, reported that 41.4 million Adderall prescriptions were issued last year, up 10.4% from 2020.

A version of this article first appeared on WebMD.com.

Recommended Reading

Overshadowed by opioids, meth is back and hospitalizations surge
Journal of Clinical Outcomes Management
Eczema increases the risk of impaired mental health among children
Journal of Clinical Outcomes Management
Decide ADHD pharmacotherapy based on medication onset, duration of action
Journal of Clinical Outcomes Management
ADHD meds may boost treatment retention in comorbid addiction
Journal of Clinical Outcomes Management
Will COVID-19 result in more ADHD cases? A debate
Journal of Clinical Outcomes Management
Late-breaking news on trajectory of ADHD remission headlines world conference
Journal of Clinical Outcomes Management
New obesity target? Dopamine circuit in brainstem affects satiety
Journal of Clinical Outcomes Management
ADHD med may reduce apathy in Alzheimer’s disease
Journal of Clinical Outcomes Management
New AAD guidelines eye comorbidities in adults with atopic dermatitis
Journal of Clinical Outcomes Management
Multiple mental health woes? Blame it on genetics
Journal of Clinical Outcomes Management